top headlines
Ofichem has consolidated its multiple business units into a single [...]
DeepCyte, a techbio company developing AI-driven toxicology tools for drug [...]
Movers & Shakers
sponsored content
As Rare Disease Day 2026 highlights the challenges faced by [...]
As the pharmaceutical industry moves from AI experimentation to execution, [...]
On World Cancer Day (WCD), Affibody highlights its progress in [...]
Other news
A new analyst report from William Blair has highlighted Carterra [...]
Life Biosciences has raised $80m in a Series D financing [...]
Scaling production of adeno-associated virus vectors remains a key barrier [...]
New analysis from Phesi suggests 6.7% of globally recruiting clinical [...]
A study published in Proceedings of the National Academy of [...]
AC Immune has amended its collaboration agreement with Eli Lilly [...]
